Targeting thyroid diseases with TSH receptor analogs.

Area of Science:

• Endocrinology and pharmacology
• Molecular and cellular biology
• Drug discovery

Background:

• The TSH receptor (TSHR) is crucial for thyroid function and implicated in diseases like hyperthyroidism and thyroid cancer.
• Current treatments for thyroid conditions have limitations and side effects.
• Graves' ophthalmopathy presents significant treatment challenges.

Purpose of the Study:

• To review recent advances in TSH analogs, particularly small molecules.
• To explore the potential clinical applications of these novel TSH analogs.
• To highlight the therapeutic promise for various thyroid-related disorders.

Main Methods:

• Review of in vitro and in vivo research models.
• High-throughput screening methods for identifying TSH analogs.
• Analysis of small molecules with agonist, antagonist, and inverse agonist activity on TSHR.

Main Results:

• Small molecules targeting TSHR have emerged as promising drug candidates.
• These analogs demonstrate diverse activities (agonist, antagonist, inverse agonist).
• Advancements suggest potential for new therapeutic strategies.

Conclusions:

• TSH analogs, especially small molecules, offer a novel therapeutic avenue.
• Further development may lead to clinical trials for Graves' disease, thyroid cancer, and osteoporosis.
• These compounds hold potential for improved management of thyroid disorders.